BIOCENTECH APS: Financial statements 2024
CVR: 25437470
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BIOCENTECH APS (CVR 25437470) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -17,690 and a net result of DKK -19,363 compared with DKK -16,380 the year before. Equity in the 2024 report amounted to DKK -46,636.
- Gross Profit
- DKK -17,690
- Profit/Loss
- DKK -19,363
- Equity
- DKK -46,636
- Total Assets
- DKK 74,982
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -18 t. | -19 t. | -47 t. | - |
| 2023 | - | -15 t. | -16 t. | -27 t. | - |
| 2022 | - | -5 t. | -6 t. | 3 t. | - |
| 2021 | - | -6 t. | -7 t. | 9 t. | - |
| 2020 | - | -6 t. | -7 t. | 17 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BIOCENTECH APS has published its annual report for 2023. Gross profit came to DKK -14,792, and the net result was DKK -16,380.
About BIOCENTECH APS
BIOCENTECH APS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company is registered under the industry Fremstilling af andre maskiner til specielle formål i.a.n.. The management consists of Aleksander Nærvig. The company is owned by NÆRVIG GROUP ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -13,000 and a net result of DKK -14,669 compared with DKK -19,363 the year before. Equity in the 2025 report amounted to DKK -61,305.